Text Size

Role of the Autonomic Nervous System in HIV-Lipodystrophy

This study has been completed.
Sponsor:
Collaborator:
HW&J Hector-Stiftung
Information provided by:
Hannover Medical School
ClinicalTrials.gov Identifier:
NCT00149097
First received: September 6, 2005
Last updated: May 6, 2008
Last verified: May 2008
History of Changes
  Purpose

The study aims to characterise the influence of the autonomic nervous system activity on the development of the lipodystrophy syndrome in HIV-infected patients by measuring heart rate variability and various metabolic pathways in HIV patients receiving highly active antiretroviral therapy.


Condition
HIV Infections
Lipodystrophy-Syndrome

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Autonomic Nervous System Activity in the Pathogenesis of the Lipodystrophy Syndrome in HIV-Infected Patients.

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Further study details as provided by Hannover Medical School:

Biospecimen Retention:   Samples Without DNA

Serum and Plasma


Enrollment: 54
Study Start Date: March 2005
Study Completion Date: January 2007
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with confirmed HIV infection and no active opportunistic infection during the last 2 months.

Criteria

Inclusion Criteria:

  • HIV-infection
  • Age above 18 years
  • No AIDS defining event during last 6 months
  • No infection during last 6 weeks
  • No concommitant drug interfering with insulin sensitivity and ANS-activity
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00149097

Locations
Germany
Hannover Medical School
Hannover, Germany, 30625
Sponsors and Collaborators
Hannover Medical School
HW&J Hector-Stiftung
Investigators
Principal Investigator: Georg MN Behrens, MD Hannover Medical School
  More Information

Publications:

Responsible Party: Prof. Georg Behrens, Hannover Medical School
ClinicalTrials.gov Identifier: NCT00149097     History of Changes
Other Study ID Numbers: ANS-M26
Study First Received: September 6, 2005
Last Updated: May 6, 2008
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Additional relevant MeSH terms:
HIV Infections
Acquired Immunodeficiency Syndrome
Lipodystrophy
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
 Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
Slow Virus Diseases
Skin Diseases, Metabolic
Skin Diseases
Lipid Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on May 22, 2013